Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ACS Diagnosis to Therapy Justin E Davies
Author(s): Justin E Davies Start date: Sep 01, 2015

Anticoagulation

Intervention
Author(s): Robert F Storey , Roxana Mehran , Dominick J Angiolillo , et al Added: 1 year ago
This broadcast series 'Where Do Potent P2Y12 Inhibitors Fit Into Current Practice?'will reappraise potent P2Y12 inhibitors, as evidence accumulates to support their broader use. At this juncture, there is still some uncertainty around patient selection, initiation and long-term management. The first broadcast in this series, focused on Acute Coronary Syndrome (ACS).In this on-demand… View more

MI/ACS
Added: 3 years ago
18 August 2015, Marlow, UK – Cardiovascular publisher and media company, Radcliffe Cardiology, today announce an innovative digital education initiative at this year’s European Society of Cardiology (ESC) annual meeting in London, UK (29 August – 2 September 2015). In collaboration with the Imperial College NHS Trust and Interventional Cardiology Review (ICR) and funded by industry partners’… View more
Added: 3 years ago Source:  bayer
NICE Issues Interim Appraisal Consultation Document (ACD) Recommending Xarelto®▼(rivaroxaban) 2.5mg as an option for Secondary Prevention in ACS UK NICE ACD guidance recommends 2.5mg Xarelto®twice daily in combination with aspirin alone or aspirin plus clopidogrel or ticlopidine as an option forsecondary prevention in acute coronary syndrome (ACS) in… View more
Author(s): Syed Khurram Mushtaq Gardezi Added: 3 years ago
Today, in cardiology, acute coronary syndrome (ACS) is one of the most common presentations in hospitals. Usually, the history and presenting features of ACS are very typical. However, some patients have an atypical presentation, which can pose a problem for prompt diagnosis and management, leading to an overall increase in morbidity and mortality in such patients. Case Presentation A 61-year… View more

Vascular Disease and Surgery

Imaging & Diagnostics
Added: 3 years ago
Treating acute coronary syndrome (ACS) patients with ticagrelor for 12 months is cost-effective, shows an analysis of the PLATO study. “The results of the cost-effectiveness analysis show that treatment with ticagrelor is associated with a cost per quality-adjusted life year (QALY) of approximately €2,800 when compared with generic clopidogrel,” comment the researchers. “This finding was… View more
Ranil de Silva
Research Area(s) / Expertise:

Coronary Artery Disease and Myocardial Infarction

Coronary Interventions

 Job title: Senior Lecturer in Clinical Cardiology and Consultant Interventional Cardiologist
Dr Ranil de Silva is a Senior Lecturer in Clinical Cardiology and Consultant Interventional Cardiologist at the Royal Brompton Hospital, where he leads the Specialist Angina Service. Dr de Silva completed his training in general and interventional cardiology in London, including at the Royal Brompton, Hammersmith and St Mary’s Hospitals. He undertook post-doctoral research at the Division of… View more
Early Rule-out of Acute Myocardial Infarction with Copeptin - An Interview with Professor Martin Möckel
Author(s): Martin Mockel Added: 10 years ago
Fast. Effective. Safe. Acute myocardial infarction (AMI) may safely be ruled out by testing a single blood sample at patient presentation. In a recently-completed intervention study, using a Copeptin-based diagnostic algorithm enabled immediate discharge of 2/3 of patients with suspected acute coronary syndrome (ACS) from the emergency department. At 30 days, patients managed using Copeptin… View more

MI/ACS
Acute Myocardial Infarction with Copeptin
Author(s): Bertil Lindahl Added: 10 years ago
Fast. Effective. Safe. Acute myocardial infarction (AMI) may safely be ruled out by testing a single blood sample at patient presentation. In a recently-completed intervention study, using a Copeptin-based diagnostic algorithm enabled immediate discharge of 2/3 of patients with suspected acute coronary syndrome (ACS) from the emergency department. At 30 days, patients managed using Copeptin had… View more

MI/ACS